Skip to main content

Articles

Page 26 of 108

  1. Exposure to high levels of endogenous estrogens is a main risk factor for breast cancer in women, and in observational studies was found to be inversely associated with physical activity. The objective of the ...

    Authors: Kaoutar Ennour-Idrissi, Elizabeth Maunsell and Caroline Diorio
    Citation: Breast Cancer Research 2015 17:139
  2. Authors: Eleanor Cornford, Anne Turnbull, Jonathan James, Rachel Tsang, Tayeba Akram, Helen Burrell, Lisa Hamilton, Sarah Tennant, Mark Bagnall, Shama Puri, Graham Balls, Yan Chen and Vivienne Jones
    Citation: Breast Cancer Research 2015 17(Suppl 1):O1

    This article is part of a Supplement: Volume 17 Supplement 1

  3. Increased animal fat consumption is associated with increased premenopausal breast cancer risk in normal weight, but not overweight, women. This agrees with our previous findings in obesity-resistant BALB/c mi...

    Authors: Mark D. Aupperlee, Yong Zhao, Ying Siow Tan, Yirong Zhu, Ingeborg M. Langohr, Erin L. Kirk, Jason R. Pirone, Melissa A. Troester, Richard C. Schwartz and Sandra Z. Haslam
    Citation: Breast Cancer Research 2015 17:138
  4. The diversity of human breast cancer subtypes has led to the hypothesis that breast cancer is actually a number of different diseases arising from cells at various stages of differentiation. The elusive nature...

    Authors: Lei Bao, Robert D. Cardiff, Paul Steinbach, Karen S. Messer and Lesley G. Ellies
    Citation: Breast Cancer Research 2015 17:137
  5. As the release of tumor-associated DNA into blood circulation is a common event in patients with cancer, screening of plasma or serum DNA may provide information on genetic and epigenetic profiles associated w...

    Authors: Heidi Schwarzenbach and Klaus Pantel
    Citation: Breast Cancer Research 2015 17:136
  6. In triple negative breast cancers (TNBC) the initial response to chemotherapy is often favorable, but relapse and chemotherapy resistance frequently occur in advanced disease. Hence there is an urgent need for...

    Authors: Esther H. Lips, Magali Michaut, Marlous Hoogstraat, Lennart Mulder, Nicolle JM Besselink, Marco J. Koudijs, Edwin Cuppen, Emile E. Voest, Rene Bernards, Petra M. Nederlof, Jelle Wesseling, Sjoerd Rodenhuis and Lodewyk FA Wessels
    Citation: Breast Cancer Research 2015 17:134
  7. The N9831 trial demonstrated the efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2 (HER2) locally positive tumors by protein or gene analysis. We used the 21-gene assa...

    Authors: Edith A. Perez, Frederick L. Baehner, Steven M. Butler, E. Aubrey Thompson, Amylou C. Dueck, Farid Jamshidian, Diana Cherbavaz, Carl Yoshizawa, Steven Shak, Peter A. Kaufman, Nancy E. Davidson, Julie Gralow, Yan W. Asmann and Karla V. Ballman
    Citation: Breast Cancer Research 2015 17:133
  8. Breast cancer exhibits significant molecular, histological, and pathological diversity. Factors that impact this heterogeneity are poorly understood; however, transformation of distinct normal cell populations...

    Authors: Daria Drobysheva, Brittni Alise Smith, Maria McDowell, Katrin P. Guillen, Huseyin Atakan Ekiz and Bryan E. Welm
    Citation: Breast Cancer Research 2015 17:132
  9. Abundance of immune cells has been shown to have prognostic and predictive significance in many tumor types. Beyond abundance, the spatial organization of immune cells in relation to cancer cells may also have...

    Authors: Carlo C. Maley, Konrad Koelble, Rachael Natrajan, Athena Aktipis and Yinyin Yuan
    Citation: Breast Cancer Research 2015 17:131
  10. Toll-like receptors (TLRs) are a family of pattern recognition receptors that are expressed on cells of the innate immune system. The ligands can be pathogen derived (pathogen associated molecular patterns; PA...

    Authors: Meliha Mehmeti, Roni Allaoui, Caroline Bergenfelz, Lao H. Saal, Stephen P. Ethier, Martin E. Johansson, Karin Jirström and Karin Leandersson
    Citation: Breast Cancer Research 2015 17:130
  11. Obese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear.

    Authors: Peter Widschwendter, Thomas WP Friedl, Lukas Schwentner, Nikolaus DeGregorio, Bernadette Jaeger, Amelie Schramm, Inga Bekes, Miriam Deniz, Krisztian Lato, Tobias Weissenbacher, Bernd Kost, Ulrich Andergassen, Julia Jueckstock, Julia Neugebauer, Elisabeth Trapp, Peter A. Fasching…
    Citation: Breast Cancer Research 2015 17:129
  12. There are an estimated 60,000 new cases of ductal carcinoma in situ (DCIS) each year. A lack of understanding in DCIS pathobiology has led to overtreatment of more than half of patients. We profiled the tempor...

    Authors: Hanan S. Elsarraj, Yan Hong, Kelli E. Valdez, Whitney Michaels, Marcus Hook, William P. Smith, Jeremy Chien, Jason I. Herschkowitz, Melissa A. Troester, Moriah Beck, Marc Inciardi, Jason Gatewood, Lisa May, Therese Cusick, Marilee McGinness, Lawrence Ricci…
    Citation: Breast Cancer Research 2015 17:128
  13. Breast cancer is the most common female malignancy worldwide and, despite improvements in treatment modalities, there are increased chances of recurrence and metastasis in a substantial number of cases and it ...

    Authors: Abdul K. Siraj, Shaham Beg, Zeenath Jehan, Sarita Prabhakaran, Maqbool Ahmed, Azhar R.Hussain, Fouad Al-Dayel, Asma Tulbah, Dahish Ajarim and Khawla S. Al-Kuraya
    Citation: Breast Cancer Research 2015 17:127
  14. Authors: Stephanie Verbeke, Elodie Richard, Elodie Monceau, Xenia Schmidt, Benoit Rousseau, Valerie Velasco, David Bernard, Herve Bonnefoi, Gaetan MacGrogan and Richard D Iggo
    Citation: Breast Cancer Research 2015 17:126

    The original article was published in Breast Cancer Research 2014 16:504

  15. It has been shown in some articles that genetic and epigenetic abnormalities cannot only be found in tumor tissues but also in adjacent regions that appear histologically normal. This phenomenon is metaphorica...

    Authors: Melanie Spitzwieser, Elisabeth Holzweber, Georg Pfeiler, Stefan Hacker and Margit Cichna-Markl
    Citation: Breast Cancer Research 2015 17:125
  16. The status of tumor-infiltrating lymphocytes (TILs) has been recently proposed to predict clinical outcome of patients with breast cancer. We therefore studied the prognostic significance of CD8+ TILs and FOXP3+ ...

    Authors: Minoru Miyashita, Hironobu Sasano, Kentaro Tamaki, Hisashi Hirakawa, Yayoi Takahashi, Saki Nakagawa, Gou Watanabe, Hiroshi Tada, Akihiko Suzuki, Noriaki Ohuchi and Takanori Ishida
    Citation: Breast Cancer Research 2015 17:124
  17. HOX genes play vital roles in growth and development, however, atypical redeployment of these genes is often associated with steroidal adaptability in endocrine cancers. We previously identified HOXC11 to be an ...

    Authors: Azlena Ali, Laura Creevey, Yuan Hao, Damian McCartan, Peadar O’Gaora, Arnold Hill, Leonie Young and Marie McIlroy
    Citation: Breast Cancer Research 2015 17:123
  18. Hypoxia is a well-characterized driver of aggressive cancer phenotypes, including metastasis. Accumulating evidence suggests that, in addition to having local effects, the consequences of tumour hypoxia can be...

    Authors: Sakari Vanharanta
    Citation: Breast Cancer Research 2015 17:122
  19. Bisphosphonates (BPs) are approved as standard therapy in breast cancer for the treatment of bone metastases, since they were demonstrated to reduce the prevalence of skeletal-related events including fracture...

    Authors: Daniele Santini, Luciano Stumbo, Chiara Spoto, Loretta D’Onofrio, Francesco Pantano, Michele Iuliani, Marco fioramonti, Alice Zoccoli, Giulia Ribelli, Vladimir Virzì, Bruno Vincenzi and Giuseppe Tonini
    Citation: Breast Cancer Research 2015 17:121
  20. Physical inactivity and overweight are risk factors for postmenopausal breast cancer. The effect of physical activity may be partially mediated by concordant weight loss. We studied the effect on serum sex hor...

    Authors: Willemijn AM. van Gemert, Albertine J. Schuit, Job van der Palen, Anne M. May, Jolein A. Iestra, Harriet Wittink, Petra H. Peeters and Evelyn M. Monninkhof
    Citation: Breast Cancer Research 2015 17:120
  21. The seventh annual meeting of the European Network of Breast Development and Cancer Laboratories, held in Weggis, Switzerland, in April 2015, was focused on techniques for the study of normal and cancer stem c...

    Authors: Marina A. Glukhova, Nancy Hynes, Maria dM Vivanco, Renée van Amerongen, Robert B. Clarke and Mohamed Bentires-Alj
    Citation: Breast Cancer Research 2015 17:119
  22. Breast density, commonly quantified as the percentage of mammographically dense tissue area, is a strong breast cancer risk factor. We investigated associations between breast cancer and fully automated measur...

    Authors: Brad M. Keller, Jinbo Chen, Dania Daye, Emily F. Conant and Despina Kontos
    Citation: Breast Cancer Research 2015 17:117
  23. A large body size is associated with larger breast cancer tumours at diagnosis. Standard regression models for tumour size at diagnosis are not sufficient for unravelling the mechanisms behind the association.

    Authors: Linda Abrahamsson, Kamila Czene, Per Hall and Keith Humphreys
    Citation: Breast Cancer Research 2015 17:116
  24. Breast cancer researchers use cell lines to model myriad phenomena ranging from DNA repair to cancer stem cell phenotypes. Though appropriate, and even requisite, for many studies, the suitability of cell line...

    Authors: Krista Marie Vincent, Scott D. Findlay and Lynne Marie Postovit
    Citation: Breast Cancer Research 2015 17:114
  25. Pathologists currently diagnose breast lesions through histologic assessment, which requires fixation and tissue preparation. The diagnostic criteria used to classify breast lesions are qualitative and subject...

    Authors: Jessica L. Dobbs, Jenna L. Mueller, Savitri Krishnamurthy, Dongsuk Shin, Henry Kuerer, Wei Yang, Nirmala Ramanujam and Rebecca Richards-Kortum
    Citation: Breast Cancer Research 2015 17:105
  26. The truncated form of human epidermal growth factor receptor 2 (p95HER2) lacks the HER2 extracellular domain and has been associated with poor prognosis and resistance to trastuzumab. In the present study, the...

    Authors: Galatea Kallergi, Sofia Agelaki, Maria A. Papadaki, Dimitris Nasias, Alexios Matikas, Dimitris Mavroudis and Vassilis Georgoulias
    Citation: Breast Cancer Research 2015 17:113
  27. The steady increase in the incidence of obesity among adults has been paralleled with higher levels of obesity-associated breast cancer. While recent studies have suggested that adipose stromal/stem cells (ASC...

    Authors: Amy L. Strong, Jason F. Ohlstein, Brandi A. Biagas, Lyndsay V. Rhodes, Dorothy T. Pei, H. Alan Tucker, Claire Llamas, Annie C. Bowles, Maria F. Dutreil, Shijia Zhang, Jeffrey M. Gimble, Matthew E. Burow and Bruce A. Bunnell
    Citation: Breast Cancer Research 2015 17:112
  28. PALB2 is emerging as a high-penetrance breast cancer predisposition gene in the order of BRCA1 and BRCA2. However, large studies that have evaluated the full gene rather than just the most common variants in bot...

    Authors: Ella R. Thompson, Kylie L. Gorringe, Simone M. Rowley, Michelle W. Wong-Brown, Simone McInerny, Na Li, Alison H. Trainer, Lisa Devereux, Maria A. Doyle, Jason Li, Richard Lupat, Martin B. Delatycki, Gillian Mitchell, Paul A. James, Rodney J. Scott and Ian G. Campbell
    Citation: Breast Cancer Research 2015 17:111
  29. Mammographic density is an established breast cancer risk factor with a strong genetic component and can be increased in women using menopausal hormone therapy (MHT). Here, we aimed to identify genetic variant...

    Authors: Anja Rudolph, Peter A. Fasching, Sabine Behrens, Ursula Eilber, Manjeet K. Bolla, Qin Wang, Deborah Thompson, Kamila Czene, Judith S. Brand, Jingmei Li, Christopher Scott, V. Shane Pankratz, Kathleen Brandt, Emily Hallberg, Janet E. Olson, Adam Lee…
    Citation: Breast Cancer Research 2015 17:110
  30. Decoding transcriptional effects of experimental tissue–tissue or cell–cell interactions is important; for example, to better understand tumor–stroma interactions after transplantation of human cells into mous...

    Authors: Indira V. Chivukula, Daniel Ramsköld, Helena Storvall, Charlotte Anderberg, Shaobo Jin, Veronika Mamaeva, Cecilia Sahlgren, Kristian Pietras, Rickard Sandberg and Urban Lendahl
    Citation: Breast Cancer Research 2015 17:109
  31. Screening mammography has contributed to a significant increase in the diagnosis of ductal carcinoma in situ (DCIS), raising concerns about overdiagnosis and overtreatment. Building on prior observations from lin...

    Authors: Anosheh Afghahi, Erna Forgó, Aya A. Mitani, Manisha Desai, Sushama Varma, Tina Seto, Joseph Rigdon, Kristin C. Jensen, Megan L. Troxell, Scarlett Lin Gomez, Amar K. Das, Andrew H. Beck, Allison W. Kurian and Robert B. West
    Citation: Breast Cancer Research 2015 17:108
  32. Lysyl oxidase (LOX; ExPASy ENZYME entry: EC 1.4.3.13) and members of the LOX-like family, LOXL1–LOXL4, are copper-dependent enzymes that can modify proteins of the extracellular matrix. Expression of LOX is el...

    Authors: Melinda Wuest, Manuela Kuchar, Sai Kiran Sharma, Susan Richter, Ingrit Hamann, Monica Wang, Larissa Vos, John R. Mackey, Frank Wuest and Reik Löser
    Citation: Breast Cancer Research 2015 17:107
  33. Cellular senescence is a terminal cell proliferation arrest that can be triggered by oncogenes. One of the traits of oncogene-induced senescence (OIS) is the so-called senescence-associated secretory phenotype...

    Authors: Beatriz Morancho, Águeda Martínez-Barriocanal, Josep Villanueva and Joaquín Arribas
    Citation: Breast Cancer Research 2015 17:106
  34. Breast cancer in premenopausal women (preM) is frequently associated with worse prognosis compared to that in postmenopausal women (postM), and there is evidence that preM estrogen receptor-positive (ER+) tumo...

    Authors: Serena Liao, Ryan J. Hartmaier, Kandace P. McGuire, Shannon L. Puhalla, Soumya Luthra, Uma R. Chandran, Tianzhou Ma, Rohit Bhargava, Francesmary Modugno, Nancy E. Davidson, Steve Benz, Adrian V. Lee, George C. Tseng and Steffi Oesterreich
    Citation: Breast Cancer Research 2015 17:104
  35. Alcohol consumption may promote aromatization of androgens to estrogens, which may partly explain the observations linking alcohol consumption to higher breast cancer risk. Whether alcohol consumption is assoc...

    Authors: Hanne Frydenberg, Vidar G. Flote, Ine M. Larsson, Emily S. Barrett, Anne-Sofie Furberg, Giske Ursin, Tom Wilsgaard, Peter T. Ellison, Anne McTiernan, Anette Hjartåker, Grazyna Jasienska and Inger Thune
    Citation: Breast Cancer Research 2015 17:103
  36. By convention, a contralateral breast cancer (CBC) is treated as a new primary tumor, independent of the first cancer (BC1). Although there have been indications that the second tumor (BC2) sometimes may repre...

    Authors: Sara Alkner, Man-Hung Eric Tang, Christian Brueffer, Malin Dahlgren, Yilun Chen, Eleonor Olsson, Christof Winter, Sara Baker, Anna Ehinger, Lisa Rydén, Lao H. Saal, Mårten Fernö and Sofia K. Gruvberger-Saal
    Citation: Breast Cancer Research 2015 17:102
  37. The immune system plays a major role in cancer progression. In solid tumors, 5-40 % of the tumor mass consists of tumor-associated macrophages (TAMs) and there is usually a correlation between the number of TA...

    Authors: Sofia Sousa, Régis Brion, Minnamaija Lintunen, Pauliina Kronqvist, Jouko Sandholm, Jukka Mönkkönen, Pirkko-Liisa Kellokumpu-Lehtinen, Susanna Lauttia, Olli Tynninen, Heikki Joensuu, Dominique Heymann and Jorma A. Määttä
    Citation: Breast Cancer Research 2015 17:101
  38. Several studies have suggested that anti-diabetic insulin analogue treatment might increase cancer risk. The aim of this study was to review the postulated association between insulin and insulin analogue trea...

    Authors: Heleen K Bronsveld, Bas ter Braak, Øystein Karlstad, Peter Vestergaard, Jakob Starup-Linde, Marloes T Bazelier, Marie L De Bruin, Anthonius de Boer, Christine L E Siezen, Bob van de Water, Jan Willem van der Laan and Marjanka K Schmidt
    Citation: Breast Cancer Research 2015 17:100
  39. Basal-like breast cancer (BLBC) is an aggressive subtype often characterized by distant metastasis, poor patient prognosis, and limited treatment options. Therefore, the discovery of alternative targets to res...

    Authors: Panagiotis Papageorgis, Sait Ozturk, Arthur W. Lambert, Christiana M. Neophytou, Alexandros Tzatsos, Chen K. Wong, Sam Thiagalingam and Andreas I. Constantinou
    Citation: Breast Cancer Research 2015 17:98
  40. Insulin analogues are designed to have improved pharmacokinetic parameters compared to regular human insulin. This provides a sustained control of blood glucose levels in diabetic patients. All novel insulin a...

    Authors: Bas ter Braak, Steven Wink, Esmee Koedoot, Chantal Pont, Christine Siezen, Jan Willem van der Laan and Bob van de Water
    Citation: Breast Cancer Research 2015 17:97
  41. Overweight and obesity in childhood and adolescence are associated with reduced breast cancer risk, independent of adult body mass index (BMI). These associations may be mediated through breast density.

    Authors: Kimberly A. Bertrand, Heather J. Baer, E. John Orav, Catherine Klifa, John A. Shepherd, Linda Van Horn, Linda Snetselaar, Victor J. Stevens, Nola M. Hylton and Joanne F. Dorgan
    Citation: Breast Cancer Research 2015 17:95

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions